Vaccinex, Inc.
ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME

Last updated:

Abstract:

Compositions and methods are provided for treating diseases associated with CXCL13 expression, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CXCL13 monoclonal antibodies have been developed to neutralize CXCL13.

Status:
Application
Type:

Utility

Filling date:

24 Sep 2020

Issue date:

25 Mar 2021